Beaumont Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,049
Closed -$477K 325
2022
Q3
$477K Sell
1,049
-52
-5% -$24.9K 0.05% 175
2022
Q2
$531K Sell
1,101
-6
-0.5% -$2.97K 0.05% 171
2022
Q1
$544K Buy
1,107
+16
+1% +$7.31K 0.04% 197
2021
Q4
$506K Buy
1,091
+25
+2% +$10.5K 0.04% 209
2021
Q3
$397K Hold
1,066
0.03% 239
2021
Q2
$407K Sell
1,066
-45
-4% -$17.2K 0.03% 248
2021
Q1
$399K Sell
1,111
-3
-0.3% -$965 0.03% 225
2020
Q4
$358K Buy
1,114
+6
+0.5% +$1.84K 0.03% 239
2020
Q3
$298K Sell
1,108
-94
-8% -$25.3K 0.03% 262
2020
Q2
$316K Buy
1,202
+3
+0.3% +$800 0.03% 225
2020
Q1
$272K Sell
1,199
-4
-0.3% -$1.09K 0.03% 201
2019
Q4
$363K Buy
1,203
+257
+27% +$70.7K 0.04% 207
2019
Q3
$227K Buy
946
+1
+0.1% +$274 0.02% 247
2019
Q2
$267K Buy
945
+170
+22% +$46.4K 0.03% 205
2019
Q1
$222K Buy
+775
New +$224K 0.02% 213

Other funds holding ELV

Beaumont Financial Advisors's ELV Position: Q4 2022 in Review

Beaumont Financial Advisors sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 1,049 shares — an estimated $477K sold.

Beaumont Financial Advisors first reported a position in ELV in Q1 2019 and held it in 15 quarters. The position peaked at $544K in Q1 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Beaumont Financial Advisors reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Beaumont Financial Advisors sold 1,049 Elevance Health shares in Q4 2022, an estimated $477K.
  • Beaumont Financial Advisors first reported a position in Elevance Health in Q1 2019 and held it in 15 quarters.
  • Beaumont Financial Advisors's Elevance Health position peaked at $544K in Q1 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Beaumont Financial Advisors's 13F filing for Q4 2022, filed 25 Jan 2023.